Focus Areas: Energy, Sleep, Body Composition, Recovery Energy: People ask about a steadier daytime drive
Assuming Eli Lilly follows a similar timeline to tirzepatide, the earliest possible FDA approval for retatrutide would likely occur in late 2027 or 2028, depending on Phase 3 trial results and regulatory review timelines
Are Building a Recovery-Focused Supplement Protocol: If you already use supplements like collagen peptides, omega-3 fatty acids, curcumin, or other recovery-supporting compounds and want to explore synergistic additions, BPC-157 fits logically into a comprehensive tissue support stack
GHK-Cu, chemically known as glycyl-histyl-lysine copper complex, is named Copper Tripeptide-1 under INCI standards
They inhibit intestinal CYP3A4 activity, reducing the breakdown of tacrolimus and raising blood levels